A 32-year-old woman with a 52 mg LNG-IUS in situ for contraception develops symptoms and signs consistent with pelvic inflammatory disease (PID). What...

Question

A 32-year-old woman with a 52 mg LNG-IUS in situ for contraception develops symptoms and signs consistent with pelvic inflammatory disease (PID). What is the most appropriate management?

Accepted Answer

Start appropriate antibiotics and leave the LNG-IUS in situ; review after 48-72 hours

Answer

Remove the LNG-IUS immediately before starting antibiotics

Answer

Remove the LNG-IUS and do not offer any IUC in the future

Answer

Admit to hospital for intravenous antibiotics regardless of severity

Answer

Defer antibiotic treatment until microbiological results are available

uk-dfsrh MCQ (SBA): PID Management with IUC in Situ

A 32-year-old woman with a 52 mg LNG-IUS in situ for contraception develops symptoms and signs consistent with pelvic inflammatory disease (PID). What is the most appropriate management?